Kyorin Pharmaceutical Co Ltd. Stock Analysis KYRNF
United States Health Care Small Cap
KYORIN Pharmaceutical Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products through its subsidiaries. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 1,998 full-time employees. The company went IPO on 2006-03-10. The Pharmaceuticals segment is mainly engaged in the manufacture, purchase, sales and testing of pharmaceutical products, the purchase of raw materials for pharmaceuticals, the evaluation of technologies, the inspection, analysis and negotiation of license affiliations, the operations related to clinical trials and information gathering such as searching for drug discovery seeds, as well as the drug candidate compound discovery research and compound evaluation business. The firm also conducts the diagnostic businesses and verifies and creates research targets that are directly linked to drug discovery.
Kyorin Pharmaceutical Co Ltd (KYRNF) Chart
Financial Metrics & Statements of Kyorin Pharmaceutical Co Ltd (KYRNF)
FAQ's for Kyorin Pharmaceutical Co Ltd (KYRNF)
As of August 2026, Kyorin Pharmaceutical Co Ltd KYRNF is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Kyorin Pharmaceutical Co Ltd using these criteria to determine its compliance status.
Muslim investors may consider investing in Kyorin Pharmaceutical Co Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Kyorin Pharmaceutical Co Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Kyorin Pharmaceutical Co Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Kyorin Pharmaceutical Co Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Kyorin Pharmaceutical Co Ltd (KYRNF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.